Financial Instruments (Tables)

9 Months Ended

Oct. 02, 2021

Notes To Financial Statements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table summarizes the company’s fair value of interest rate swaps (in thousands):

	Condensed Consolidated Balance Sheet Presentation	Oct 2, 2021		Jan 2, 2021
Fair value	Other assets	$	1,465	$	—
Fair value	Accrued expenses	$	768	$	14,075
Fair value	Other non-current liabilities	$	29,982	$	37,018

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The impact on earnings from interest rate swaps was as follows (in thousands):

		Three Months Ended				Nine Months Ended
	Presentation of Gain/(loss)	Oct 2, 2021		Sep 26, 2020		Oct 2, 2021		Sep 26, 2020
Gain/(loss) recognized in accumulated other comprehensive income	Other comprehensive income	$	(340)	$	(1,545)	$	7,117	$	(44,949)
Gain/(loss) reclassified from accumulated other comprehensive income (effective portion)	Interest expense	$	(4,461)	$	(5,158)	$	(14,691)	$	(10,419)